Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for NYSE:ZMH
104.45
+0.04 (0.04%)
After Hours: 104.45 0.00 (0.00%)
Dec 8, 4:47PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 103.78 - 104.80
52 week 88.27 - 133.21
Open 104.45
Vol / Avg. 1.27M/2.66M
Mkt cap 20.88B
P/E 58.45
Div/yield 0.24/0.92
EPS 1.79
Shares 200.30M
Beta 1.24
Inst. own 87%
Jan 26, 2017
Q4 2016 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:30AM EST - Add to calendar
Nov 15, 2016
Zimmer Biomet Holdings Inc at Stifel Healthcare Conference - Webcast
Oct 31, 2016
Q3 2016 Zimmer Biomet Holdings Inc Earnings Call - Webcast
Oct 31, 2016
Q3 2016 Zimmer Biomet Holdings Inc Earnings Release
Sep 15, 2016
Zimmer Biomet Holdings Inc at Mozaic IR INVESTIndiana Equity Conference - Webcast
Sep 12, 2016
Zimmer Biomet Holdings Inc at Morgan Stanley Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 8.62% 2.44%
Operating margin 10.67% 7.79%
EBITD margin - 33.54%
Return on average assets 2.39% 0.79%
Return on average equity 6.60% 1.79%
Employees 17,500 -
CDP Score - 62 E

Address

345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Stuart G. Kleopfer President, Americas
Age: 53
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Adam Rudolph Johnson Group President, Spine, Dental, CMF and Thoracic
Age: 38
Bio & Compensation  - Reuters
David A. Nolan Jr. Group President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Bone Healing
Age: 50
Bio & Compensation  - Reuters
Daniel E. Williamson Group President, Joint Reconstruction
Age: 50
Bio & Compensation  - Reuters